» Articles » PMID: 20132313

Inhibitory Effects of Gallic Acid Ester Derivatives on Saccharomyces Cerevisiae Multidrug Resistance Protein Pdr5p

Overview
Journal FEMS Yeast Res
Specialty Microbiology
Date 2010 Feb 6
PMID 20132313
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Overexpression of the Saccharomyces cerevisiae ABC transporter Pdr5p confers resistance to a range of structurally unrelated xenobiotics. This property allows Pdr5p to be used as a target for novel multidrug resistance reversal reagents or chemosensitizers. Herein, we report the effects of gallic acid derivatives with substitutions either on the ester moiety or in the benzene ring on the activity of Pdr5p. Compounds with a longer side chain (8-16 carbons) resulted in greater inhibition of Pdr5p ATPase. Derivatives with side chains of 8-12 carbons that retained hydroxyl groups on the benzene ring extensively inhibited Pdr5p ATPase activity. These compounds almost completely inhibited the efflux of the Pdr5p fluorescent substrate Rhodamine 6G and at 25 muM chemosensitized the Pdr5p-overexpressing strain AD124567 to fluconazole (0.4 mg mL(-1)). Gallic acid derivatives may be a new class of Pdr5p inhibitors.

Citing Articles

Mediterranean Shrub Species as a Source of Biomolecules against Neurodegenerative Diseases.

Chaves N, Nogales L, Montero-Fernandez I, Blanco-Salas J, Alias J Molecules. 2023; 28(24).

PMID: 38138621 PMC: 10745362. DOI: 10.3390/molecules28248133.


An update on the potential mechanism of gallic acid as an antibacterial and anticancer agent.

Keyvani-Ghamsari S, Rahimi M, Khorsandi K Food Sci Nutr. 2023; 11(10):5856-5872.

PMID: 37823155 PMC: 10563697. DOI: 10.1002/fsn3.3615.


Overview of Beneficial Effects of (Poly)phenol Metabolites in the Context of Neurodegenerative Diseases on Model Organisms.

Carregosa D, Mota S, Ferreira S, Alves-Dias B, Loncarevic-Vasiljkovic N, Crespo C Nutrients. 2021; 13(9).

PMID: 34578818 PMC: 8464690. DOI: 10.3390/nu13092940.


β-Lapachone enhances the antifungal activity of fluconazole against a Pdr5p-mediated resistant Saccharomyces cerevisiae strain.

de Moraes D, Cardoso K, Domingos L, Pinto M, Monteiro R, Ferreira-Pereira A Braz J Microbiol. 2020; 51(3):1051-1060.

PMID: 32157667 PMC: 7455662. DOI: 10.1007/s42770-020-00254-9.


Characterisation of an ABC transporter of a resistant Candida glabrata clinical isolate.

Rocha D, Reis de Sa L, Pinto A, Junqueira M, Silva E, Borges R Mem Inst Oswaldo Cruz. 2018; 113(4):e170484.

PMID: 29412345 PMC: 5851027. DOI: 10.1590/0074-02760170484.